Overview
More than 50 million people suffer from chronic pain. Despite its prevalence and complex treatment, studies show that up to 75% of patients may not be taking their pain medications as prescribed. To minimize this risk of medication misuse or abuse, more and more physicians are utilizing urine drug testing.

Crosby was tapped to re-brand Ameritox as a leader in this growth industry.

Insight
Research revealed that physicians are looking for the best science, data and support to help them improve patient outcomes. Tapping into this need, we positioned Ameritox as a new standard of chronic pain care. With unique data, tools and resources, Ameritox helps physicians achieve the best possible outcomes for their patients and their practices.

Approach
We defined a whole new category in urine drug monitoring—Pain Medication Monitoring Solutions^SM Armed with a unique brand strategy and visualization, we developed all the tools to tell the Ameritox story at every possible touchpoint.

We created a collateral system, website, microsites, print and online advertising, trade show displays and videos to support the entire product life cycle from sales to ongoing account management.

Results
The brand launched to immediate success. Ameritox is rapidly gaining recognition as a leader and advocate for the highest quality chronic pain care.